Umbralisib

Umbralisib Basic information
Product Name:Umbralisib
Synonyms:TGR-1202;RP-5264;RP-5264 TGR-1202;TGR1205;Umbralisib;Umbralisib (TGR-1202);4H-1-Benzopyran-4-one, 2-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-;(S)-2-(1-(4-AMINO-3-(3-FLUORO-4-ISOPROPOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)ETHYL)-6-FLUORO-3-(3-FLUOROPHENYL)-4H-CHROMEN-4-ONE
CAS:1532533-67-7
MF:C31H24F3N5O3
MW:571.55
EINECS:
Product Categories:
Mol File:1532533-67-7.mol
Umbralisib Structure
Umbralisib Chemical Properties
Boiling point 737.4±60.0 °C(Predicted)
density 1.43±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 1 mg/ml; DMSO: 1 mg/ml
form solid
pka3.79±0.30(Predicted)
Safety Information
MSDS Information
Umbralisib Usage And Synthesis
DescriptionUmbralisib (TGR-1202) tosylate is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib tosylate exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib tosylate can be used for haematological malignancies reseach. 
UsesRP 5264 is a novel PI3K inhibitor that enhances Brentuximab Vedotin-induced lymphoma cell death.
SynthesisThe synthesis of Umbralisib is as follows:
To a solution of intermediate 13 (0.134 g, 0.494 mmol) in THF (2.0 ml), intermediate 5 (0.150 g, 0.494 mmol) and triphenylphosphine (0.194 g, 0.741 mml) were added and stirred at RT for 5 min. Diisopropylazodicarboxylate ( 0.15 ml, 0.749 mmol) was added heated to 45°C. After 2h, the reaction mixture was quenched with with water and extracted with ethyl acetate. The organic layer was dried over sodium sulphate and concentrated under reduced pressure. The crude product was purified by column chromatography with ethyl acetate : petroleum ether to afford Umbralisib as an off-white solid (0.049 g, 20 %).
synthesis of Umbralisib.png

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.